These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

805 related items for PubMed ID: 19490101

  • 1. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
    Salvi A, Sabelli C, Moncini S, Venturin M, Arici B, Riva P, Portolani N, Giulini SM, De Petro G, Barlati S.
    FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
    Yan D, Zhou X, Chen X, Hu DN, Dong XD, Wang J, Lu F, Tu L, Qu J.
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
    [Abstract] [Full Text] [Related]

  • 3. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.
    Li N, Fu H, Tie Y, Hu Z, Kong W, Wu Y, Zheng X.
    Cancer Lett; 2009 Mar 08; 275(1):44-53. PubMed ID: 19006648
    [Abstract] [Full Text] [Related]

  • 4. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells.
    Fornari F, Milazzo M, Chieco P, Negrini M, Calin GA, Grazi GL, Pollutri D, Croce CM, Bolondi L, Gramantieri L.
    Cancer Res; 2010 Jun 15; 70(12):5184-93. PubMed ID: 20501828
    [Abstract] [Full Text] [Related]

  • 5. miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway.
    Tan S, Li R, Ding K, Lobie PE, Zhu T.
    FEBS Lett; 2011 Jul 21; 585(14):2229-34. PubMed ID: 21658389
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.
    Liu WH, Yeh SH, Lu CC, Yu SL, Chen HY, Lin CY, Chen DS, Chen PJ.
    Gastroenterology; 2009 Feb 21; 136(2):683-93. PubMed ID: 19027010
    [Abstract] [Full Text] [Related]

  • 7. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.
    Wang C, Song B, Song W, Liu J, Sun A, Wu D, Yu H, Lian J, Chen L, Han J.
    J Gastroenterol Hepatol; 2011 Nov 21; 26(11):1630-7. PubMed ID: 21557766
    [Abstract] [Full Text] [Related]

  • 8. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.
    Fornari F, Gramantieri L, Giovannini C, Veronese A, Ferracin M, Sabbioni S, Calin GA, Grazi GL, Croce CM, Tavolari S, Chieco P, Negrini M, Bolondi L.
    Cancer Res; 2009 Jul 15; 69(14):5761-7. PubMed ID: 19584283
    [Abstract] [Full Text] [Related]

  • 9. Down-regulation of c-Met expression inhibits human HCC cells growth and invasion by RNA interference.
    Xie B, Xing R, Chen P, Gou Y, Li S, Xiao J, Dong J.
    J Surg Res; 2010 Aug 15; 162(2):231-8. PubMed ID: 19765730
    [Abstract] [Full Text] [Related]

  • 10. In vitro c-met inhibition by antisense RNA and plasmid-based RNAi down-modulates migration and invasion of hepatocellular carcinoma cells.
    Salvi A, Arici B, Portolani N, Giulini SM, De Petro G, Barlati S.
    Int J Oncol; 2007 Aug 15; 31(2):451-60. PubMed ID: 17611703
    [Abstract] [Full Text] [Related]

  • 11. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
    Li XF, Yan PJ, Shao ZM.
    Oncogene; 2009 Nov 05; 28(44):3937-48. PubMed ID: 19701247
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion.
    Li Q, Wang G, Shan JL, Yang ZX, Wang HZ, Feng J, Zhen JJ, Chen C, Zhang ZM, Xu W, Luo XZ, Wang D.
    J Gastroenterol Hepatol; 2010 Jan 05; 25(1):164-71. PubMed ID: 19793168
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma.
    Chan CF, Yau TO, Jin DY, Wong CM, Fan ST, Ng IO.
    Clin Cancer Res; 2004 Jun 15; 10(12 Pt 1):4140-9. PubMed ID: 15217951
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells.
    Wei W, Hu Z, Fu H, Tie Y, Zhang H, Wu Y, Zheng X.
    Oncol Rep; 2012 Aug 15; 28(2):701-6. PubMed ID: 22664953
    [Abstract] [Full Text] [Related]

  • 15. Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma.
    Diao S, Zhang JF, Wang H, He ML, Lin MC, Chen Y, Kung HF.
    Proteomics; 2010 Oct 15; 10(20):3723-31. PubMed ID: 20859956
    [Abstract] [Full Text] [Related]

  • 16. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.
    Fornari F, Gramantieri L, Ferracin M, Veronese A, Sabbioni S, Calin GA, Grazi GL, Giovannini C, Croce CM, Bolondi L, Negrini M.
    Oncogene; 2008 Sep 25; 27(43):5651-61. PubMed ID: 18521080
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.
    Wong QW, Lung RW, Law PT, Lai PB, Chan KY, To KF, Wong N.
    Gastroenterology; 2008 Jul 25; 135(1):257-69. PubMed ID: 18555017
    [Abstract] [Full Text] [Related]

  • 18. Effects of miR-193a and sorafenib on hepatocellular carcinoma cells.
    Salvi A, Conde I, Abeni E, Arici B, Grossi I, Specchia C, Portolani N, Barlati S, De Petro G.
    Mol Cancer; 2013 Dec 13; 12():162. PubMed ID: 24330766
    [Abstract] [Full Text] [Related]

  • 19. Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocyte growth factor, c-met, and transcription factor Ets-1.
    Jiang Y, Xu W, Lu J, He F, Yang X.
    Biochem Biophys Res Commun; 2001 Sep 07; 286(5):1123-30. PubMed ID: 11527416
    [Abstract] [Full Text] [Related]

  • 20. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L, Xi-Ran Z.
    Hepatogastroenterology; 2004 Sep 07; 51(56):515-25. PubMed ID: 15086194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.